Amgen has potential to compete with established leaders in obesity drugs

Amgen has potential to compete with established leaders in obesity drugs

Source: 
Biopharma Reporter
snippet: 

On January 8, Amgen presented at JP Morgan’s 42nd Annual Healthcare Conference 2024 (JPM24), highlighting its pillars of business.